Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients

Table 2 The comparison of ratio of lymphocytes to monocytes in patients with different clinicopathological features

Clinicopathological features	LMR	t	P value
Sex		-0.976	0.333
Male	2.61 ± 0.45
Female	2.74 ± 0.65
Age (yr)		0.283	0.778
< 60 year	2.70 ± 0.49
≥ 60 year	2.66 ± 0.57
Ann Arbor stage		-4.559	< 0.001
I-II	2.41 ± 0.52
III-IV	3.06 ± 0.64
ECOG scores		-3.280	0.002
< 2	2.52 ± 0.50
≥ 2	2.98 ± 0.62
IPI scores		-2.339	0.022
0-1	2.54 ± 0.52
2-5	2.82 ± 0.46
Hans		-0.338	0.737
GCB	2.64 ± 0.43
Non GCB	2.68 ± 0.50
BCL2 expression		-0.173	0.863
< 50%	2.66 ± 0.44
≥ 50%	2.68 ± 0.51
Ki-67		0.442	0.660
< 70%	2.71 ± 0.55
≥ 70%	2.65 ± 0.52

LMR: Ratio of lymphocytes to monocytes; IPI: International prognostic index; ECOG: Eastern Cooperative Oncology Group; GCB: Germinal center B-cell.